ABSTRACT
A new 11 amino acid linear peptide named roseabol A (1) and the known compound 13-oxo-trans-9,10-epoxy-11(E)-octadecenoic acid (2) were isolated from the fungus Clonostachys rosea. Combined NMR and MS analysis revealed that roseabol A (1) contained amino acid residues characteristic of the peptaibol family of peptides such as isovaline, α-aminoisobutyric acid, hydroxyproline, leucinol, and an N-terminal isovaleric acid moiety. The amino acid sequence was established by a combination of NMR studies and tandem MS fragmentation analyses, and the absolute configurations of the constituent amino acids of 1 were determined by the advanced Marfey's method. Compound 2 showed inhibitory activity against Merkel cell carcinoma, a rare and difficult-to-treat type of skin cancer, with an IC50 value of 16.5 µM.
Subject(s)
Antineoplastic Agents/pharmacology , Carcinoma, Merkel Cell/drug therapy , Hypocreales/chemistry , Peptaibols/chemistry , Peptaibols/pharmacology , Skin Neoplasms/drug therapy , Amino Acid Sequence , Antineoplastic Agents/chemistry , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/metabolism , Cell Line, Tumor , Humans , Magnetic Resonance Spectroscopy/methods , Molecular Structure , Skin Neoplasms/chemistry , Skin Neoplasms/metabolismABSTRACT
Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine malignancy of the skin. The cell of origin of MCC is thus far unknown and proposed cells of origin include Merkel cells, pro-/pre- or pre-B cells, epithelial stem cells, and dermal stem cells. In this study, we aimed to shed further light on the possibility that a subset of MCC tumors arise from epithelial stem cells of the skin by examining the expression of hair follicle and epidermal stem cell markers in MCC and normal human skin. We also aimed to elucidate any correlation between the expression of these markers and tumor Merkel cell polyomavirus (MCPyV) status or other clinicopathological characteristics or patient survival. Expression of CK19, SOX9, LGR5, and LRIG1 in MCC and normal human skin was studied by immunohistochemistry, and the staining patterns or intensities were statistically correlated with patient, tumor, MCPyV, and survival parameters. In a cohort of 137 cases of MCC, we observed dot-like immunoexpression of CK19 in 30 cases (22.1%) and homogeneous expression in 103 cases (75.7%). We also observed positive immunoexpression of SOX9 in 21 cases (15.3%), LGR5 in 118 cases (86.1%), and LRIG1 in 117 cases (86.0%). Immunoexpression of LRIG1 was found to correlate with better overall and MCC-specific survival. We observed frequent immunoexpression of several hair follicle and epidermal stem cell markers in MCC and found LRIG1 to be a positive prognostic marker in MCC.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Epithelial Cells/chemistry , Membrane Glycoproteins/analysis , Neoplastic Stem Cells/chemistry , Skin Neoplasms/chemistry , Adult , Aged , Aged, 80 and over , Carcinoma, Merkel Cell/mortality , Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/therapy , Epithelial Cells/pathology , Female , Humans , Immunohistochemistry , Keratin-19/analysis , Male , Middle Aged , Neoplastic Stem Cells/pathology , Phenotype , Prognosis , Receptors, G-Protein-Coupled/analysis , SOX9 Transcription Factor/analysis , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Skin Neoplasms/therapyABSTRACT
The association of immune markers and clinicopathologic features and patient outcome has not been extensively studied in Merkel cell carcinoma (MCC). We correlated tumoral PD-L1 and IDO1 expression, and intratumoral CD8+ and FoxP3+ lymphocytes count with clinicopathologic variables, Merkel cell polyomavirus (MCPyV) status, and patient outcomes in a series of 132 MCC. By univariate analyses, tumoral PD-L1 expression >1% and combined tumoral PD-L1 >1% and high intratumoral FoxP3+ lymphocyte count correlated with improved overall survival (OS) (p = 0.016, 0.0072), MCC-specific survival (MSS) (p = 0.019, 0.017), and progression-free survival (PFS) (p = 0.043, 0.004, respectively). High intratumoral CD8+ and FoxP3+ lymphocyte count correlated with longer MSS (p = 0.036) and improved PFS (p = 0.047), respectively. Ulceration correlated with worse OS and worse MSS. Age, male gender, and higher stage (3 and 4) significantly correlated with worse survival. MCPyV positivity correlated with immune response. By multivariate analyses, only ulceration and age remained as independent predictors of worse OS; gender and stage remained for shorter PFS. Tumoral PD-L1 expression and increased density of intratumoral CD8+ lymphocytes and FoxP+ lymphocytes may represent favorable prognosticators in a subset of MCCs. Tumoral PD-L1 expression correlated with intratumoral CD8+ and FoxP3+ lymphocytes, which is supportive of an adaptive immune response.
Subject(s)
B7-H1 Antigen/biosynthesis , CD8-Positive T-Lymphocytes/immunology , Carcinoma, Merkel Cell/mortality , Indoleamine-Pyrrole 2,3,-Dioxygenase/biosynthesis , Lymphocytes, Tumor-Infiltrating/immunology , Neoplasm Proteins/biosynthesis , Skin Neoplasms/mortality , T-Lymphocyte Subsets/immunology , Adaptive Immunity , Age Factors , Aged , Aged, 80 and over , Biomarkers, Tumor , CD8-Positive T-Lymphocytes/chemistry , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/immunology , Carcinoma, Merkel Cell/virology , Female , Forkhead Transcription Factors/analysis , Head and Neck Neoplasms/chemistry , Head and Neck Neoplasms/immunology , Head and Neck Neoplasms/mortality , Head and Neck Neoplasms/virology , Humans , Kaplan-Meier Estimate , Lymphocyte Count , Male , Merkel cell polyomavirus/isolation & purification , Middle Aged , Multivariate Analysis , Neoplasm Staging , Neoplasms, Second Primary/chemistry , Neoplasms, Second Primary/immunology , Neoplasms, Second Primary/mortality , Neoplasms, Second Primary/virology , Prognosis , Progression-Free Survival , Proportional Hazards Models , Sex Factors , Skin Neoplasms/chemistry , Skin Neoplasms/immunology , Skin Neoplasms/virology , Skin Ulcer/etiology , Tumor Virus InfectionsABSTRACT
ABSTRACT: In skin containing hair follicles, specialized epithelial structures known as "touch domes (TDs)" are located where the Merkel cells are clustered. We explored the histogenetic relationship between intraepidermal and dermal Merkel cell carcinomas (MCCs) and investigated which transformed progenitor cells can develop into intraepidermal MCC. We encountered an association between an extremely rare case of dermal and intraepidermal MCC with squamous cell carcinoma, which was examined using standard immunohistochemical methods with various epithelial, neuroendocrine, and TD markers including several immunohistochemical markers. Differential expression levels of CK20 and CD56 were found between intraepidermal and dermal MCCs, indicating molecularly distinct MCC populations. CK15 and CK17, expressed in TDs, were partially expressed in the intraepidermal neuroendocrine component at the tumor periphery in intraepidermal MCC with squamous cell carcinoma. These differences may suggest that the origin of dermal and intraepidermal MCCs is different under pathological conditions. We hypothesize that intraepidermal MCC is derived from tissue-specific stem cells localized within TDs.
Subject(s)
Carcinoma, Merkel Cell/pathology , Carcinoma, Squamous Cell/pathology , Keratins/analysis , Merkel Cells/pathology , Neoplasms, Complex and Mixed/pathology , Neoplastic Stem Cells/pathology , Skin Neoplasms/pathology , Aged, 80 and over , Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Carcinoma, Squamous Cell/chemistry , Cell Lineage , Female , Humans , Immunohistochemistry , Merkel Cells/chemistry , Neoplasms, Complex and Mixed/chemistry , Neoplastic Stem Cells/chemistry , Skin Neoplasms/chemistryABSTRACT
Neuroendocrine differentiation is characterized by endocrine and neuronal features with prominent dense secretory granules and neuropeptides. Neuroendocrine differentiation of skin tumors is of unknown clinical significance. Nonetheless, the acknowledgment of this line of differentiation is important to prevent diagnostic pitfalls and subsequent inappropriate management. This review aims at summarizing the skin neoplasms that can express neuroendocrine markers.
Subject(s)
Cell Differentiation , Neuroendocrine Tumors/pathology , Skin Neoplasms/pathology , Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/pathology , Diagnosis, Differential , Humans , Immunohistochemistry , Neuroendocrine Tumors/chemistry , Predictive Value of Tests , Skin Neoplasms/chemistryABSTRACT
Merkel cell carcinoma (MCC) is an uncommon, but aggressive neoplasm with neuroendocrine differentiation that occurs on sun-damaged skin of the elderly. Because its clinical presentation is usually nonspecific, the diagnosis is often made after histopathologic evaluation. Most cases are intradermal. Epidermal involvement is uncommon, whereas MCC limited to the epidermis is extremely rare. Here, we describe a case of MCC in an 88-year-old man with an extraordinary histopathologic presentation, namely nested intraepidermal proliferation of neoplastic cells highly resembling melanoma in situ.
Subject(s)
Carcinoma, Merkel Cell/pathology , Cell Differentiation , Cell Proliferation , Melanoma/pathology , Skin Neoplasms/pathology , Aged, 80 and over , Biomarkers, Tumor/analysis , Biopsy , Carcinoma, Merkel Cell/chemistry , Diagnosis, Differential , Humans , Immunohistochemistry , Male , Melanoma/chemistry , Predictive Value of Tests , Skin Neoplasms/chemistryABSTRACT
Merkel cell carcinoma (MCC) is a rare and highly aggressive neuroendocrine carcinoma of unknown origin. We performed a retrospective histologic review of primary cutaneous MCCs diagnosed from 1997 to 2018 in several clinical institutions and literature review to determine the frequency of various unusual morphologic appearances of MCC. Of the 136 primary MCCs identified, intraepidermal carcinoma or epidermotropism was noted in 11/136 (8%) cases. An association with pilar cyst in 1/136 (0.7%) case, with actinic keratosis in 2/136 (1.5%) cases, with either invasive or in situ squamous cell carcinoma (SCC) in 14/136 (10%) cases, with poroma in 1/136 (0.7%), and with basal cell carcinoma in 1/136 (0.7%) case was noted. Trabecular pattern and rosettes were noted in 7/136 (5%) and 3/136 (2%) cases, respectively. There was one case of metastatic MCC in a lymph node with chronic lymphocytic leukemia and one rare case of metastatic MCC and SCC in a lymph node. Although uncommon, differentiation toward other cell lineage can be observed in both primary and metastatic MCCs. The tumor can assume a variety of histologic appearances including association with SCC, basal cell carcinoma, melanocytic neoplasm, and follicular cyst; as well as exhibit glandular, sarcomatous, and mesenchymal differentiation. This diversity of morphologic appearance of MCC reflects the complexity of its underlying pathogenesis.
Subject(s)
Carcinoma, Merkel Cell/pathology , Merkel Cells/pathology , Skin Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/immunology , Cell Differentiation , Diagnosis, Differential , Humans , Immunocompromised Host , Immunohistochemistry , Lymphatic Metastasis , Merkel Cells/chemistry , Merkel Cells/immunology , Poland , Predictive Value of Tests , Prognosis , Retrospective Studies , Risk Factors , Skin Neoplasms/chemistry , Skin Neoplasms/immunology , Taiwan , United StatesABSTRACT
The literature suggests that p63 expression in Merkel cell carcinoma (MCC) is associated with a poor prognosis. p63 immunohistochemistry marks the 2 main isoforms of this transcriptional protein: TAp63 (tumor suppressor-like properties) and ∆Np63 (oncogenic properties). Little information about the isoform of relevance in MCC exists. p40 immunohistochemistry specifically marks ∆Np63, and using comparative, semiquantitative expression of p63 and p40, we sought to clarify the issue. Our cohort of 53 cases (28 men and 25 women, median age 79 years, interquartile range 71-88) was stratified by morphology and viral status. Immunohistochemistry (p63, p40, and cytokeratin 5/6) was performed, H-scores for nuclear expression of p63 and p40 were derived (2 observers; positivity ≥ 10), and interobserver agreement was evaluated. Clinical, pathological, and outcome data were documented. The results were analyzed statistically. Mortality amounted to 57% (median follow-up 686 days, interquartile range 292-1599). Positivity for Merkel cell polyomavirus was observed in 29 (55%) of cases. Expression of p63 and p40 was present in 36 (69%) and 4 (8%) of cases, respectively. Increased age (P = .0241), negative Merkel cell polyomavirus status (P = .0185), and p63 positivity (P = .0012) were significantly associated with mortality. The latter 2 variables were highly correlated (P = .004). The interclass correlation between the 2 sets of H-scores was 0.95. Our findings support an association between p63 expression and reduced overall survival in MCC and show consistency in scoring this prognostic parameter. TAp63 is the dominant isoform of the protein involved. The paradoxical tumor suppressor-like activity of this isoform in p63-positive MCCs with reduced overall survival requires further study.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Immunohistochemistry , Skin Neoplasms/chemistry , Transcription Factors/analysis , Tumor Suppressor Proteins/analysis , Aged , Aged, 80 and over , Carcinoma, Merkel Cell/mortality , Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/virology , Female , Humans , Male , Merkel cell polyomavirus/isolation & purification , Observer Variation , Predictive Value of Tests , Prognosis , Protein Isoforms , Reproducibility of Results , Retrospective Studies , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Skin Neoplasms/virologySubject(s)
Carcinoma, Merkel Cell/metabolism , Nerve Tissue Proteins/biosynthesis , Receptors, Nerve Growth Factor/biosynthesis , Skin Neoplasms/metabolism , Aged , Aged, 80 and over , Carcinoma, Merkel Cell/chemistry , Female , Humans , Male , Nerve Tissue Proteins/analysis , Prognosis , Receptors, Nerve Growth Factor/analysis , Retrospective Studies , Skin Neoplasms/chemically inducedABSTRACT
Our recent work regarding Merkel cell carcinoma sentinel lymph node (SLN) metastasis found that "solid" pattern microscopic metastasis conferred worse prognosis than the "nonsolid" ones. The goals of the present study were to (1) compare the prognostic significance/outcomes of 2 diagnostic groups-patients with a nonsolid pattern of SLN metastasis and those with diagnostically negative SLN biopsies (SLNB), and (2) evaluate the durability of SLN metastasis after extensive sectioning. Five-level, step-wise sectioning at 250-µm intervals was performed in all SLN blocks with an immunohistochemical stain for CK20 on all levels. The presence and pattern of metastases were recorded and analyzed as were corresponding patient and tumor parameters. Median follow-up durations for all patients (n=38), positive SLNB (n=16) and negative SLNB (n=22) groups were 56.3, 50.4, and 66.8 months, respectively. Overall survival (OS) and disease-specific survival (DSS) did not differ between the 2 diagnostic groups (OS P=0.65, DSS P=0.37) but did differ by immune status (immunocompetent vs. immunosuppressed, OS P=0.03, DSS P=0.005) and primary tumor category (OS P<0.0001, DSS P=0.001). On deeper sectioning, all 16 diagnostically positive SLNB continued to show nonsolid microscopic metastasis, and 32% (7/22) diagnostically negative SLNB revealed nonsolid metastasis. DSS was worse for sinusoidal-pattern metastasis versus all others (P=0.02). Five of 38 patients (13%) died of disease; the only immunocompetent patient had sinusoidal-pattern metastasis discovered in a diagnostically negative SLNB. Our data suggest that outcome for nonsolid metastasis is similar to that of negative SLNB with the exception of the sinusoidal pattern, which was associated with worse outcome. Larger studies are warranted to quantify and compare microscopic metastatic tumor burden by pattern and confirm whether the sinusoidal pattern confers an intermediate prognostic risk between solid and other nonsolid microscopic metastases.
Subject(s)
Carcinoma, Merkel Cell/secondary , Sentinel Lymph Node/pathology , Skin Neoplasms/pathology , Aged , Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/mortality , Carcinoma, Merkel Cell/therapy , Disease Progression , Disease-Free Survival , Female , Humans , Immunohistochemistry , Keratin-20/analysis , Lymphatic Metastasis , Male , Middle Aged , Ohio , Predictive Value of Tests , Retrospective Studies , Risk Factors , Sentinel Lymph Node/chemistry , Sentinel Lymph Node Biopsy , Skin Neoplasms/chemistry , Skin Neoplasms/mortality , Skin Neoplasms/therapy , Texas , Time FactorsABSTRACT
Merkel cell carcinoma (MCC) is a rare malignant tumor of the skin. The development of MCC on non-sun-exposed skin is extremely rare, with few cases reported in the literature. The present authors aimed to highlight the characteristic features and treatment options of this tumor. The present authors present a 50-year-old man who developed MCC on the left gluteal region (non-sun-exposed skin). After surgery with clear margins, adjuvant radiotherapy was given. Three months after radiotherapy, lymphatic recurrence was observed and he was treated with chemotherapy. On follow-up, systemic metastases were found and palliative treatment was planned.
Subject(s)
Carcinoma, Merkel Cell/secondary , Lymph Nodes/pathology , Skin Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy , Buttocks , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/diagnostic imaging , Carcinoma, Merkel Cell/therapy , Humans , Immunohistochemistry , Lymph Nodes/chemistry , Lymph Nodes/diagnostic imaging , Lymphatic Metastasis , Male , Margins of Excision , Middle Aged , Palliative Care , Positron Emission Tomography Computed Tomography , Radiotherapy, Adjuvant , Skin Neoplasms/chemistry , Skin Neoplasms/therapy , Treatment OutcomeABSTRACT
The literature records many examples of Merkel cell carcinoma (MCC) exhibiting aberrant immunohistochemical profiles. These can lead to diagnostic difficulty. The objectives of the current study were (1) to examine the immunohistochemical profile of different subsets of MCC to determine whether predictable subset-specific patterns exist and (2) to establish whether shared immunophenotypic patterns might reveal links between individual subsets, as demonstrated previously at a genetic level. In 52 cases of MCC, stratified by viral status and morphology, we studied 5 markers commonly used in the diagnostic evaluation of these tumors (CK20, CK7, chromogranin, neurofilament and TTF-1). Expression of these proteins was recorded as quantitative (H-scores) and absolute (positive vs negative) variables. In general, our data indicate that the "classical" or expected panel (CK20+, NF+, Chromo+, TTF-1, CK7-) is observed significantly more often in pure Merkel cell polyomavirus (MCPyV)-positive than in MCPyV-negative cases (78% vs 25%; P = .002). Neurofilament was less frequently encountered in MCPyV-negative than in MCPyV-positive tumors (66.7% vs 100%; P = .001) and expression of TTF-1 (37.5% vs 3.6%; P = .003) and CK7 (45.8 vs 14.3; P = .02) was more frequent. No significant immonophenotypic differences were observed between pure and combined MCPyV-negative tumors. Recognition of the more aberrant immunohistochemical profile of MCPyV-negative MCC should inform the diagnostic approach to this tumor. Moreover, the shared aberrant immunophenotype in pure and combined MCPyV-negative tumors supports a link between these entities and serves to separate them from MCPyV-positive tumors.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Immunohistochemistry , Skin Neoplasms/chemistry , Carcinoma, Merkel Cell/pathology , Chromogranins/analysis , DNA-Binding Proteins/analysis , Diagnosis, Differential , Humans , Keratin-20/analysis , Keratin-7/analysis , Neurofilament Proteins/analysis , Phenotype , Predictive Value of Tests , Prognosis , Skin Neoplasms/pathology , Transcription Factors/analysisABSTRACT
Merkel cell carcinoma (MCC) is an extremely aggressive skin cancer that must be distinguished from other basaloid cutaneous neoplasms that have different treatments and prognoses. This is sometimes challenging in small shave specimens, crushed samples, lymph nodes, and core needle biopsies. Insulinoma-associated protein 1 (INSM1) immunohistochemistry is a sensitive nuclear marker of neuroendocrine differentiation. INSM1 staining was performed on 56 MCC (47 primary tumors, 9 nodal metastases), 50 skin control cases that included basal cell carcinomas, basaloid squamous cell carcinomas, Bowen disease, sebaceous neoplasms, melanoma, and B-cell lymphomas, and 28 lymph node control cases that included metastatic neuroendocrine neoplasms, melanomas, squamous cell carcinomas, lymphomas, and adenocarcinomas. Percent of staining nuclei (0, <25%, 25% to 50%, 50% to 75%, >75%) and intensity (weak, moderate, strong) were recorded for each sample. All 56 MCC expressed INSM1. By comparison, synaptophysin, CK20, and chromogranin were expressed in 96%, 92%, and 32% of MCC, respectively. While the 3 conventional markers showed significant variability in staining intensity and distribution, INSM1 stained >75% tumor nuclei in 89% of MCC and 50% to 75% of tumor nuclei in 11%. Staining intensity was strong in 85% and moderate in 15%. None of the 50 cutaneous basaloid non-MCC neoplasms in the control group stained with INSM1, and among the lymph node controls 5 of 5 neuroendocrine neoplasms expressed INSM1, confirming that INSM1 staining cannot distinguish MCC from metastatic extracutaneous neuroendocrine carcinoma. INSM1 holds promise as a neuroendocrine marker that can distinguish MCC from its mimickers in the skin and improve detection of sentinel lymph node metastases.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Immunohistochemistry , Lymph Nodes/chemistry , Repressor Proteins/analysis , Skin Neoplasms/chemistry , Aged, 80 and over , Carcinoma, Merkel Cell/secondary , Diagnosis, Differential , Female , Humans , Lymph Nodes/pathology , Lymphatic Metastasis , Male , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Skin Neoplasms/pathologySubject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antineoplastic Agents, Immunological/therapeutic use , Carcinoma, Merkel Cell/drug therapy , Melanoma/drug therapy , Neoplasms, Multiple Primary/drug therapy , Skin Neoplasms/drug therapy , Aged , Biomarkers, Tumor/analysis , Biopsy , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/pathology , Humans , Immunohistochemistry , Male , Melanoma/chemistry , Melanoma/secondary , Neoplasms, Multiple Primary/chemistry , Neoplasms, Multiple Primary/pathology , Remission Induction , Skin Neoplasms/chemistry , Skin Neoplasms/pathology , Tomography, X-Ray Computed , Treatment OutcomeABSTRACT
Merkel cell carcinoma and melanoma can each occur primarily in breast skin, or metastasize to the breast. The breast is a rare site of metastasis of essentially any and every type of tumor, including carcinomas, sarcomas, and hematolymphoid neoplasms, and 10-30% of breast metastases may represent the initial presentation of disease. Although metastases generally recapitulate histologic features of the primary tumor, they are diagnostically challenging given their rarity and morphologic overlap with breast carcinoma, including special types of breast cancer. Histologic clues may include lack of carcinoma in situ, lack of central elastosis, pattern of infiltration around normal breast structures, yet none of these are specific. Careful correlation with clinical history and judicious use of immunostain panels is essential in approaching these cases.
Subject(s)
Breast Neoplasms/pathology , Carcinoma, Merkel Cell/secondary , Melanoma/secondary , Skin Neoplasms/pathology , Biopsy , Breast Neoplasms/chemistry , Breast Neoplasms/secondary , Carcinoma, Merkel Cell/chemistry , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Melanoma/chemistry , Predictive Value of Tests , Skin Neoplasms/chemistryABSTRACT
Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer that mostly occurs in the elderly. Merkel cell polyomavirus (MCPyV) is detected in approximately 80% of MCCs and is associated with carcinogenesis. Hedgehog signaling pathway plays a role in human embryogenesis and organogenesis. In addition, reactivation of this pathway later in life can cause tumors. Twenty-nineMCPyV-positive and 21 MCPyV-negative MCCs were immunohistochemically stained with primary antibodies for hedgehog signaling (SHH, IHH, PTCH1, SMO, GLI1, GLI2, and GLI3) and evaluated using H-score. Polymerase chain reaction and sequence analysis for SHH and GLI1 exons were also performed. Expression of SHH was higher in MCPyV-positive MCCs than in MCPyV-negative MCCs (P<.001). Higher expression of GLI1, MCPyV infection, male sex, and Japanese ethnicity were associated with better overall survival (P=.034, P=.001, P=.042, and P=.036, respectively). Higher expression of SHH and MCPyV infection were associated with improved MCC-specific survival (P=.037 and P=.002, respectively). The mutation analysis of prognosis-related GLI1 and SHH genes in our study revealed a low frequency of mutations in the 10 exons examined, except GLI1 exon 5 (18/22 cases), all having the same silent mutation of c.576G>A. Only 2 mutations with amino acid changes were detected in MCPyV-negative MCCs only: 1 missense mutation in GLI1 exon 4 and 1 nonsense mutation in SHH-3B. Expression of SHH and GLI1 may be useful prognostic markers of MCC because increased expression was associated with better prognosis. The high rate of c.576G>A silent mutation in GLI1 exon 5 was a feature of MCC.
Subject(s)
Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/virology , Hedgehog Proteins/analysis , Merkel cell polyomavirus/isolation & purification , Signal Transduction , Skin Neoplasms/chemistry , Skin Neoplasms/virology , Zinc Finger Protein GLI1/analysis , Biomarkers, Tumor/genetics , Carcinoma, Merkel Cell/genetics , Carcinoma, Merkel Cell/pathology , Cell Transformation, Viral , DNA Mutational Analysis , Exons , Female , Hedgehog Proteins/genetics , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Prognosis , Risk Factors , Silent Mutation , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Zinc Finger Protein GLI1/geneticsABSTRACT
Merkel cell carcinoma is a primary cutaneous neuroendocrine carcinoma, which once metastatic is difficult to treat. Recent mutation analyses of Merkel cell carcinoma revealed a low number of mutations in Merkel cell polyomavirus-associated tumors, and a high number of mutations in virus-negative combined squamous cell and neuroendocrine carcinomas of chronically sun-damaged skin. We speculated that the paucity of mutations in virus-positive Merkel cell carcinoma may reflect a pathomechanism that depends on derangements of chromatin without alterations in the DNA sequence (epigenetic dysregulation). One central epigenetic regulator is the Polycomb repressive complex 2 (PRC2), which silences genomic regions by trimethylating (me3) lysine (K) 27 of histone H3, and thereby establishes the histone mark H3K27me3. Recent experimental research data demonstrated that PRC2 loss in mice skin results in the formation of Merkel cells. Prompted by these findings, we explored a possible contribution of PRC2 loss in human Merkel cell carcinoma. We examined the immunohistochemical expression of H3K27me3 in 35 Merkel cell carcinomas with pure histological features (22 primary and 13 metastatic lesions) and in 5 combined squamous and neuroendocrine carcinomas of the skin. We found a strong reduction of H3K27me3 staining in tumors with pure histologic features and virus-positive Merkel cell carcinomas. Combined neuroendocrine carcinomas had no or only minimal loss of H3K27me3 labeling. Our findings suggest that a PRC2-mediated epigenetic deregulation may play a role in the pathogenesis of virus-positive Merkel cell carcinomas and in tumors with pure histologic features.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Merkel Cell/chemistry , Histones/analysis , Merkel cell polyomavirus/isolation & purification , Polyomavirus Infections/virology , Skin Neoplasms/chemistry , Tumor Virus Infections/virology , Aged , Aged, 80 and over , Biomarkers, Tumor/genetics , Carcinoma, Merkel Cell/genetics , Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/virology , DNA Methylation , DNA Mutational Analysis , Epigenesis, Genetic , Female , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Male , Methylation , Middle Aged , Mutation , Skin Neoplasms/genetics , Skin Neoplasms/pathology , Skin Neoplasms/virologyABSTRACT
Merkel cell carcinoma is a rare aggressive primary cutaneous neuroendocrine tumor. It is associated mostly with malignant skin lesions. Rare cases in the literature described its association with benign skin adnexal lesions. We present here an additional case of Merkel cell carcinoma arising from an epidermal cyst located in the left arm of a 57-year-old male. The tumor was composed of lobules of monotonous round cells with dusty chromatin. It was positive for cytokeratin 20 and neuroendocrine markers. Patient was treated with surgical resection and radiation to the axilla. He is well and free of disease after 5 years of follow-up.
Subject(s)
Carcinoma, Merkel Cell/pathology , Epidermal Cyst/pathology , Skin Neoplasms/pathology , Biomarkers, Tumor/analysis , Biopsy , Carcinoma, Merkel Cell/chemistry , Carcinoma, Merkel Cell/surgery , Diagnosis, Differential , Epidermal Cyst/surgery , Humans , Immunohistochemistry , Male , Middle Aged , Predictive Value of Tests , Radiotherapy, Adjuvant , Skin Neoplasms/chemistry , Skin Neoplasms/surgery , Time Factors , Treatment OutcomeABSTRACT
This study investigated the nature of carcinoid-like, labyrinthine, rippled, and conventional cell arrangements in sebaceous neoplasms, focusing on vimentin expression and Merkel cell distribution in sebaceous neoplasms relative to these findings in normal sebaceous units and other sebaceous conditions. Immunohistochemistry for vimentin and cytokeratin 20 (CK20) was evaluated in carcinoid-like (n = 2), labyrinthine (n = 4), rippled (n = 3), and conventional (n = 6) sebaceomas; sebaceous mantle hyperplasia (n = 1); steatocystomas (n = 5); fibrofolliculomas (n = 4); sebaceous mantleoma (n = 1); sebaceous gland hyperplasias (n = 4); sebaceous adenomas (n = 4); and sebaceous carcinomas (n = 4) as well as normal skin tissue. The sebaceous mantle and its hamartoma (fibrofolliculoma) showed weak positivity for vimentin in the basal layer of the epithelial component and contained a few CK20-positive Merkel cells within the epithelial component, whereas mature sebaceous lobules were negative for vimentin and did not contain any Merkel cells. All sebaceomas with carcinoid-like or labyrinthine pattern highly expressed vimentin. CK20-positive Merkel cells were distributed with varying numbers in carcinoid-like pattern (2/2) and labyrinthine pattern (3/4) sebaceomas, sebaceous mantle hyperplasia (1/1), steatocystomas (3/5), fibrofolliculomas (3/4), and sebaceous mantleoma (1/1). Vimentin expression and Merkel cell distribution were observed in normal sebaceous mantles and sebaceous mantle-associated lesions, which could be evidence of a sebaceous mantle nature in the limited setting of sebaceous lesions. Furthermore, carcinoid-like/labyrinthine pattern sebaceomas also showed vimentin immunoreactivity and contained Merkel cells. Therefore, carcinoid-like/labyrinthine pattern of cell arrangement in sebaceous neoplasms may represent a morphological phenotype of sebaceous mantles.
Subject(s)
Biomarkers, Tumor/analysis , Carcinoid Tumor/chemistry , Carcinoma, Merkel Cell/chemistry , Immunohistochemistry , Merkel Cells/chemistry , Sebaceous Gland Neoplasms/chemistry , Vimentin/analysis , Biopsy , Carcinoid Tumor/pathology , Carcinoma, Merkel Cell/pathology , Humans , Keratin-20/analysis , Merkel Cells/pathology , Predictive Value of Tests , Sebaceous Gland Neoplasms/pathologyABSTRACT
Merkel cell carcinoma (MCC) is a rare primary cutaneous neuroendocrine tumor that typically occurs on the head and neck of the elderly and follows an aggressive clinical course. Merkel cell polyomavirus (MCPyV) has been identified in up to 80% of cases and has been shown to participate in MCC tumorigenesis. Complete spontaneous regression of MCC has been rarely reported in the literature. We describe a case of a 79-year-old man that presented with a rapidly growing, 3-cm mass on the left jaw. An incisional biopsy revealed MCC. Additional health issues were discovered in the preoperative workup of this patient which delayed treatment. One month after the biopsy, the lesion showed clinical regression in the absence of treatment. Wide excision of the biopsy site with sentinel lymph node dissection revealed no evidence of MCC 2 months later. The tumor cells in the patient's biopsy specimen were negative for MCPyV by polymerase chain reaction and immunohistochemistry (CM2B4 antibody, Santa Cruz, CA). The exact mechanism for complete spontaneous regression in MCC is unknown. To our knowledge, only 2 previous studies evaluated the presence of MCPyV by polymerase chain reaction in MCC with spontaneous regression. Whether the presence or absence of MCPyV correlates with spontaneous regression warrants further investigation.